Bio-Rad Laboratories - 39 Year Stock Price History | BIO

Historical daily share price chart and data for Bio-Rad Laboratories since 1980 adjusted for splits. The latest closing stock price for Bio-Rad Laboratories as of October 21, 2019 is 345.56.
  • The all-time high Bio-Rad Laboratories stock closing price was 345.56 on October 21, 2019.
  • The Bio-Rad Laboratories 52-week high stock price is 348.39, which is 0.8% above the current share price.
  • The Bio-Rad Laboratories 52-week low stock price is 220.05, which is 36.3% below the current share price.
  • The average Bio-Rad Laboratories stock price for the last 52 weeks is 293.95.
Bio-Rad Laboratories Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 301.4954 228.0800 345.5600 224.3000 345.5600 48.81%
2018 277.5328 241.4200 326.1500 220.1000 232.2200 -2.70%
2017 219.5752 182.9100 271.3000 182.9100 238.6700 30.94%
2016 149.1690 136.1900 183.4600 123.9300 182.2800 31.46%
2015 137.5260 120.3500 151.9300 113.7700 138.6600 15.01%
2014 120.8765 122.6500 133.7300 106.4800 120.5600 -2.47%
2013 118.6682 107.4600 126.0000 107.4600 123.6100 17.67%
2012 102.7218 98.0800 114.2500 92.3000 105.0500 9.38%
2011 108.0200 105.3200 126.3400 87.5400 96.0400 -7.52%
2010 94.7088 97.8700 113.6300 81.5000 103.8500 7.66%
2009 78.5782 74.4700 100.4600 53.1000 96.4600 28.08%
2008 87.1254 99.9700 108.1000 61.5200 75.3100 -27.32%
2007 82.9541 82.2200 107.5700 67.6700 103.6200 25.57%
2006 68.9380 65.4500 84.0100 57.2500 82.5200 26.10%
2005 55.5089 57.1700 66.9000 47.0600 65.4400 14.07%
2004 55.2252 58.4100 61.9000 50.0100 57.3700 -0.52%
2003 48.0377 38.2100 62.1500 33.4000 57.6700 49.02%
2002 39.7467 30.9000 50.5100 28.1250 38.7000 22.27%
2001 23.7924 16.0500 32.5250 15.0750 31.6500 99.06%
2000 12.9794 11.3100 16.7450 10.6250 15.9000 36.01%
1999 12.2611 10.3100 14.5000 9.4400 11.6900 11.33%
1998 13.1470 13.0600 16.8750 9.8750 10.5000 -19.60%
1997 13.5673 15.1900 16.3750 11.8100 13.0600 -12.93%
1996 14.6824 14.2067 18.3100 12.1250 15.0000 5.88%
1995 11.3630 9.1267 14.1667 8.4567 14.1667 53.15%
1994 6.4240 3.5000 9.6267 3.5000 9.2500 177.50%
1993 4.7750 5.7067 5.9167 3.3333 3.3333 -41.59%
1992 6.1821 6.4167 7.1267 5.3733 5.7067 -13.32%
1991 7.0525 6.0833 9.1667 5.5433 6.5833 6.76%
1990 5.8093 5.4167 7.6667 4.2067 6.1667 15.63%
1989 5.6551 5.7067 6.5433 4.7500 5.3333 -5.88%
1988 6.3804 5.2500 7.7067 4.9167 5.6667 11.48%
1987 7.6195 5.8733 10.6667 3.7500 5.0833 -11.59%
1986 5.9524 5.0556 7.6400 4.5556 5.7500 13.74%
1985 3.2334 2.1304 5.3067 2.1304 5.0556 137.31%
1984 2.2033 2.5007 2.5185 2.0741 2.1304 -14.81%
1983 2.3317 1.3511 2.8696 1.3511 2.5007 87.56%
1982 1.3124 1.5378 1.6104 0.8696 1.3333 -7.69%
1981 2.4659 2.9807 3.6667 1.2963 1.4444 -51.25%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $10.297B $2.290B
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $144.308B 26.34
Medtronic (MDT) Ireland $143.049B 20.08
Stryker (SYK) United States $80.458B 27.82
Boston Scientific (BSX) United States $53.838B 26.11
Baxter (BAX) United States $45.159B 27.38
EssilorLuxottica Societe Anonyme (ESLOY) France $32.445B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.251B 18.08
Coloplast (CLPBY) Denmark $25.596B 40.86
Lonza Group Ag (LZAGY) Switzerland $25.453B 0.00
Terumo (TRUMY) Japan $24.836B 31.00
Smith & Nephew SNATS (SNN) United Kingdom $19.091B 0.00
ResMed (RMD) United States $18.765B 35.76
Sunny Optical Technology (SNPTF) China $16.387B 0.00
Insulet (PODD) United States $9.275B 549.57
Perrigo (PRGO) Ireland $7.335B 13.51
Canopy Growth (CGC) Canada $7.079B 0.00
Hill-Rom Holdings (HRC) United States $6.788B 20.24
Haemonetics (HAE) United States $6.460B 48.76
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.231B 27.02
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.796B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.753B 0.00
NuVasive (NUVA) United States $3.507B 27.96
Neogen (NEOG) United States $3.413B 57.10
ICU Medical (ICUI) United States $3.189B 20.69
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.674B 0.00
Quidel (QDEL) United States $2.537B 25.19
Agios Pharmaceuticals (AGIO) United States $1.964B 0.00
National Vision Holdings (EYE) United States $1.818B 39.24
Cardiovascular Systems (CSII) United States $1.698B 0.00
Aphria (APHA) $1.215B 0.00
VAREX IMAGING (VREX) United States $1.119B 25.79
AtriCure (ATRC) United States $1.026B 0.00
Phibro Animal Health (PAHC) United States $0.871B 14.17
Eagle Pharmaceuticals (EGRX) United States $0.852B 21.73
Omeros (OMER) United States $0.787B 0.00
NanoString Technologies (NSTG) United States $0.752B 0.00
PetIQ (PETQ) United States $0.731B 17.26
Lantheus Holdings (LNTH) United States $0.722B 18.97
LeMaitre Vascular (LMAT) United States $0.707B 41.91
Cerus (CERS) United States $0.630B 0.00
Surmodics (SRDX) United States $0.603B 114.61
MacroGenics (MGNX) United States $0.556B 0.00
TG Therapeutics (TGTX) United States $0.524B 0.00
OraSure Technologies (OSUR) United States $0.505B 23.37
Quanterix (QTRX) United States $0.500B 0.00
Owens & Minor (OMI) United States $0.455B 13.64
Meridian Bioscience (VIVO) United States $0.426B 13.31
Utah Medical Products (UTMD) United States $0.365B 26.75
Zynex (ZYXI) United States $0.353B 37.52
BioLife Solutions (BLFS) United States $0.344B 105.56
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.317B 0.00
United Health Products (UEEC) United States $0.233B 0.00
Bovie Medical (APYX) United States $0.230B 0.00
Vapotherm (VAPO) United States $0.180B 0.00
Repro-Med Systems (REPR) United States $0.163B 0.00
Rockwell Medical (RMTI) United States $0.162B 0.00
Cytosorbents (CTSO) United States $0.151B 0.00
Female Health (VERU) United States $0.133B 0.00
Fonar (FONR) United States $0.131B 9.17
InfuSystems Holdings (INFU) United States $0.129B 0.00
Liberty Health Sciences (LHSIF) Canada $0.111B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
Chimerix (CMRX) United States $0.089B 0.00
United-Guardian (UG) United States $0.086B 20.37
Nephros (NEPH) United States $0.075B 0.00
MTech Acquisition (KERN) United States $0.060B 0.00
MRI Interventions (MRIC) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Surface Oncology (SURF) United States $0.038B 0.00
Senestech (SNES) United States $0.022B 0.00
Trinity Biotech (TRIB) Ireland $0.019B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00